One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-139677
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 37 |
Affiliation: Augusta University Health, Amsterdam UMC Location VUmc, University Medical Center, University Hospital and Clinics, Novartis (Ireland), Goethe University Frankfurt, Michigan Center for Translational Pathology, University of Michigan–Ann Arbor, Catholic University of Korea, Seoul St. Mary's Hospital, An-Institut für Qualitätssicherung in der operativen Medizin, Singapore General Hospital, Memorial Sloan Kettering Cancer Center, Hospital Universitario de La Princesa, Portland VA Medical Center, VA Portland Health Care System, South Australian Health and Medical Research Institute, Novartis (Switzerland), Sapienza University of Rome, University of Utah, Huntsman Cancer Institute, Hôpital Saint-Louis, Charité - Universitätsmedizin Berlin, Institut BergoniéAsciminib, a First-in-Class STAMP Inhibitor, Provides Durable Molecular Response in Patients (pts) with Chronic Myeloid Leukemia (CML) Harboring the T315I Mutation: Primary Efficacy and Safety Results from a Phase 1 Trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
